Cathy Zhang

Fair Allocation of Scarce Medical Resources in the Time of Covid-19

Ezekiel Emanuel, Govind Persad, Ross Upshur et al. · New England Journal of Medicine · 2020 · 3.2K citations

Public Affairs, Health Policy, Health Systems +17

Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth

Brion W. Murray, Chuangxing Guo, Joseph Piraino et al. · Proceedings of the National Academy of Sciences · 2010 · 321 citations · Full text

Medicine, Oncology, Pharmacology +15

Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor

Kevin D. Freeman‐Cook, Robert L. Hoffman, Nichol Miller et al. · Cancer Cell · 2021 · 186 citations

Life Sciences, Cancer Biology, Oncology +14

PEST Domain Mutations in Notch Receptors Comprise an Oncogenic Driver Segment in Triple-Negative Breast Cancer Sensitive to a γ-Secretase Inhibitor

Kai Wang, Qin Zhang, Danan Li et al. · Clinical Cancer Research · 2015 · 152 citations

Life Sciences, Molecular Biology, Oncology +17

Novel Tricyclic Poly(ADP-ribose) Polymerase-1 Inhibitors with Potent Anticancer Chemopotentiating Activity:  Design, Synthesis, and X-ray Cocrystal Structure

Stacie S. Canan Koch, Lars Thoresen, Jayashree Tikhe et al. · Journal of Medicinal Chemistry · 2002 · 138 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16